REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Onecare Biotech Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Onecare Biotech Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Onecare Biotech Sdn. Bhd. is an enterprise based in Malaysia. Its main office is in Subang Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on August 11, 2009. The latest financial highlights indicate a net sales revenue increase of 78.02% in 2021. Over the same period, its total assets grew by 164.37%. In 2021, Onecare Biotech Sdn. Bhd.’s net profit margin decreased by 2.82%.

Headquarters
S-08-02, 8Th Floor, First Subang, Jalan Ss15/4G
Subang Jaya; Selangor; Postal Code: 47500

Contact Details: Purchase the Onecare Biotech Sdn. Bhd. report to view the information.

Website: http://www.onecare.com.my

Basic Information
Outstanding Shares:
Purchase the Onecare Biotech Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Onecare Biotech Sdn. Bhd. report to view the information.
Incorporation Date:
August 11, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Onecare Biotech Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
78.02%▲
Total operating revenue
78.02%▲
Operating profit (EBIT)
20.74%▲
EBITDA
20.7%▲
Net Profit (Loss) for the Period
20.74%▲
Total assets
164.37%▲
Total equity
N/A
Operating Profit Margin (ROS)
-2.82%▼
Net Profit Margin
-2.82%▼
Return on Equity (ROE)
N/A
Quick Ratio
0.47%▲
Cash Ratio
0.1%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo